Information de reference pour ce titreAccession Number: | 00002548-200493020-00017.
|
Author: | Liljedahl, M 1; Bodin, L 2; Schollin, J 1
|
Institution: | (1)Department of Paediatrics, Orebro University Hospital, Sweden (2)Unit of Statistics and Epidemiology, Orebro University Hospital, Sweden
|
Title: | |
Source: | Acta Paediatrica. 93(2):211-215, February 2004.
|
Abstract: | Aim: To determine whether sepsis caused by coagulase-negative staphylococci (CoNS) is a risk factor for developing bronchopulmonary dysplasia (BPD) in premature newborns.
Methods: All newborns born at <=30 wk of gestation at Orebro University Hospital during 1994-2001 with clinical sepsis caused by CoNS (group A, n = 22) or by other bacteria (group B, n = 17) were included and compared with premature newborns without sepsis (group C, n = 53). Clinical sepsis was defined as a positive blood culture (monoculture) plus clinical symptoms and laboratory findings. BPD was defined as treatment with oxygen >21% for at least 28 d.
Results: The incidence of BPD differed between the three groups, as follows: CoNS sepsis (A) 64%, other sepsis (B) 41% and control (C) 24%. The difference between the control group and the sepsis groups was highly significant (p = 0.006). In a univariate model the crude estimates of relative risk (RR) for occurrence of BPD increased with presence of sepsis and particularly with presence of sepsis with CoNS (A: RR 2.6, 95% CI 1.5-4.6, p = 0.001; B: RR 1.7, CI 0.8-3.5, p = 0.17). When regression was performed with two additional predictive variables in multivariate models including sepsis, gestational age and mechanical ventilation (group A: RR 1.5, CI 1.1-2.0, p = 0.004; group B: RR 0.9, CI 0.6-1.4, p = 0.67), the estimates were lower.
Conclusion: The relative risk for BPD is significantly increased in premature newborns with sepsis caused by CoNS compared with those with sepsis caused by other bacteria and compared with premature newborns with no sepsis.
(C) 2004 Acta Paediatrica
|
Author Keywords: | Bronchopulmonary dysplasia; coagulase-negative staphylococci; newborn; sepsis.
|
References: | 1. Northway WH, Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline membrane disease. Bronchopulmonary dysplasia: N Engl J Med 1967; 276: 357-68.
2. Northway WH, Jr. Brochopulmonary dysplasia: Twenty-five years later. Pediatrics 1992; 89: 969-73.
3. Bancalari E, Gonzalez A. Clinical course and lung function abnormalities during development of neonatal chronic lung disease. In Bland RD, Coalson JJ, editors. Chronic lung disease in early infancy. New York: Marcel Dekker; 2000; 41-64.
4. Speer CP. New insights into the pathogenesis of pulmonary inflammation in preterm infants. Biol Neonate 2001; 79: 205-9.
5. Jobe AH, Bancalari E. Bronchopulmonary dysplasia, NICHD-NHLBI-ORD workshop. Am J Respir Crit Care Med 2001; 163: 241-64.
6. Bancalari E, Claure N, Sosenko IRS. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol 2003; 8: 63-71.
7. Gonzalez A, Sosenko IRS, Chandar J, Hummler H, Claure N, Bancalari E. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 gram or less. J Pediatr 1996; 128: 470-8.
8. Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, O'Shea TM. Risk factors for chronic lung disease in surfactant era: a North Carolina population-based study of very low birth weight infants. Pediatrics 1999; 104: 1345-50.
9. Van Marter LJ, Dammann O, Allred EN, Leviton A, Pagano M, Moore M, et al. Chorioamnionitis, mechanical ventilation and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 2002; 140: 171-6.
10. Wang EEL, Ohlsson A, Kellner JD. Association of ureaplasma urealyticum colonization with chronic lung disease of prematurity: Results of a metaanalysis. J Pediatr 1995; 127: 640-4.
11. van Waarde WM, Brus F, Okken A, Kimpen JLL. Ureaplasma urealyticum colonization, prematurity and bronchopulmonary dysplasia. Eur Resp J 1998; 10: 886-90.
12. Cordero L, Ayers LW, Davis K. Neonatal airway colonization with gram-negative bacilli: association with severity of bronchopulmonary dysplasia. Pediatr Infect Dis J 1997; 16: 18-23.
13. Cooke RWI. Factors associated with chronic lung disease in preterm infants. Arch Dis Child 1991; 66: 776-9.
14. Corcoran JD, Patterson CC, Thomas PS, Halliday HL. Reduction in the risk of bronchopulmonary dysplasia from 1980-1990: results of a multivariate logistic regression analysis. Eur J Pediatr 1993; 152: 677-81.
15. Groneck P, Schmale J, Soditt V, Stutzer H, Gotze-Speer B, Speer CP. Bronchoalveolar inflammation following airway infection in preterm infants with chronic lung disease. Pediatr Pulmonol 2001; 31: 331-8.
16. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97: 210-5.
17. Yoon BH, Romero R, Kim KS, Park JS, Ki SH, Kim BI, et al. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999; 181: 773-9.
18. Rojas MA, Gonzales A, Bancalari E, Claure N, Poole C, Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995; 126: 605-10.
19. da Silva O, Stevens D. Complications of airway management in very-low-birth-weight infants. Biol Neonate 1999; 75: 40-5.
20. Kallman J, Kihlstrom E, Sjoberg L, Schollin J. Increase of staphylococci in neonatal septicemia: a fourteen-year study. Acta Paediatr 1997; 86: 533-8.
21. Bjorkqvist M, Soderquist B, Tornqvist E, Sjoberg L, Fredlund H, Kuhn I, et al. Phenotypic and genotypic characterisation of blood isolates of coagulase-negative staphylococci in the newborn. APMIS 2002; 110: 332-9.
22. Hudac ML, Martin DJ, Egan EA, Matteson EJ, Cummings J, Jung AL, et al. A multicenter randomised masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome. Pediatrics 1997; 100: 39-50.
23. StatXact 5. Statistical software for exact nonparametric inference. Cambridge, MA: Cytel Software Corporation; 2001.
24. Stata Statistical Software. Release 7.0. College Station, TX: Stata Corporation; 2001.
25. Parker RA, Lindstrom DP, Cotton RB. Improved survival accounts for most, but not all, of the increase in bronchopulmonary dysplasia. Pediatrics 1992; 90: 663-8.
26. Baier RJ, Bocchini JA, Jr, Brown EG. Selective use of vancomycin to prevent coagulase-negative staphylococcal nosocomial bacteremia in high-risk very low birth weight infants. Pediatr Infect Dis J 1998; 17: 179-83.
27. Kacica MA, Horgan MJ, Ochoa L, Sandler R, Lepow ML, Venezia RA. Prevention of Gram-positive sepsis in neonates weighing less than 1500 grams. J Pediatr 1994; 125: 253-8.
28. Spafford PS, Sinkin RA, Cox C, Reubens L, Powell KR. Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis in neonates. J Pediatr 1994; 125: 259-63.
|
Language: | English.
|
Document Type: | NEONATAL MEDICINE.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0803-5253
|
NLM Journal Code: | bgc, 9205968
|
Annotation(s) | |
|
|